ADAM9 is over‐expressed in human ovarian clear cell carcinomas and suppresses cisplatin‐induced cell death

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|109|2|471-482

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.2, 2018-02, pp. : 471-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 687-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hematopoietic pre‐B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1313-1322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cadmium‐coordinated supramolecule suppresses tumor growth of T‐cell leukemia in mice

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 635-641

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite